Lorlatinib is an Orally Active ROS1/ALK Inhibitor for NSCLC Research
ROS1 (c-ros oncogene 1) is a receptor tyrosine kinase encoded by the gene ROS1. Importantly, ROS1 is a proto-oncogene and highly expressed in a variety of tumor cell lines, belonging…